Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
MWN-AI** Summary
Cosmos Health Inc. (NASDAQ: COSM), a diversified global healthcare company, has made headlines with its recent purchase of an additional $300,000 in Ethereum (ETH), escalating its total investment in the cryptocurrency to $1.8 million. This acquisition falls under the company's broader strategy outlined in its $300 million digital assets facility, emphasizing its commitment to expanding its digital asset portfolio. CEO Greg Siokas remarked on the continued accumulation of Ethereum, indicating a strong belief in the strategic importance of digital assets as part of the company's growth vision.
Founded in 2009, Cosmos Health operates across various sectors within the healthcare industry, including pharmaceuticals and nutraceuticals. It maintains a diverse portfolio of proprietary brands such as Sky Premium Life®, Mediterranation®, and C-Sept®, and has significant manufacturing capabilities through its subsidiary Cana Laboratories S.A., which adheres to European Good Manufacturing Practices. This positions Cosmos Health as a key player in the EU healthcare market, capable of producing pharmaceuticals, food supplements, and medical devices.
The company's strategic initiatives extend beyond asset investment, as it actively engages in R&D partnerships to develop solutions for major health challenges like obesity and diabetes, leveraging advanced technologies such as artificial intelligence for drug repurposing. Additionally, Cosmos Health is making strides in the telehealth sector following its acquisition of ZipDoctor, Inc. With an expanding presence in Greece, the UK, Europe, Asia, and North America, Cosmos Health is poised for continued growth and innovation within the global healthcare landscape.
As the company pursues its digital asset strategy while broadening its healthcare offerings, investors and stakeholders should remain aware of the risks and uncertainties inherent in these forward-looking initiatives. For further details, more information is available on the company's official websites and investor relations platforms.
MWN-AI** Analysis
Cosmos Health Inc. (NASDAQ:COSM) recently made headlines by investing an additional $300,000 in Ethereum (ETH), bringing its total investment in the cryptocurrency to $1.8 million. This move is part of the company’s broader strategy to utilize its $300 million digital assets facility aimed at diversifying its portfolio through targeted investments in digital assets. As crypto markets remain highly volatile yet promising, this acquisition reflects Cosmos Health’s confidence in Ethereum's long-term potential.
From a market perspective, this investment signals a multifaceted strategy. First, by increasing its stake in Ethereum, Cosmos is positioning itself in a key player in the evolving digital economy, particularly as blockchain technology continues to find applications beyond cryptocurrencies, including in healthcare sectors such as supply chain management and patient data security.
As the healthcare sector increasingly leans towards digital integration, Cosmos Health is well-placed to capitalize on both its traditional pharmaceutical strengths and innovative digital commitments. The recent bullish sentiment surrounding Ethereum and its upcoming upgrades could further enhance its value proposition for Cosmos Health.
Investors should note the broader implications of Cosmos Health’s actions. The company is not only leveraging digital trends; it is also seeking to tap into artificial intelligence-driven R&D partnerships and expanding telehealth services through its acquisition of ZipDoctor, Inc.
However, potential investors should exercise caution. While Cosmos Health is making strides, the inherent risks involving cryptocurrency investments, ongoing geopolitical tensions, and market fluctuations necessitate thorough due diligence. Keeping an eye on Cosmos Health’s financial health and leveraging strategies is key for making informed investment decisions. As the company continues to evolve, its diversified approach may yield substantial returns, but prospective investors should consider both the opportunities and risks associated with their investments in Cosmos Health.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $300,000 worth of Ethereum (ETH), increasing its total investment in ETH to $1.8 million.
This latest purchase was made under Cosmos Health’s previously announced $300 million digital assets facility, which supports the Company’s ongoing strategy to diversify its portfolio through strategic digital asset investments.
Greg Siokas, CEO of Cosmos Health, stated: “We have continued to increase our Ethereum holdings following last week’s purchase, bringing our total investment in ETH to $1.8 million. We remain committed to accelerating our acquisition program under our $300 million financing facility.”
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website ( www.sec.gov ). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
Disclaimer
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.
FAQ**
How does Cosmos Health Inc.'s increasing investment in Ethereum (ETH) impact its overall business strategy as a diversified healthcare group within Cosmos Holdings Inc. COSM?
What specific risks and uncertainties could affect Cosmos Holdings Inc. COSM's digital asset strategies as it seeks to implement its $300 million financing facility?
How does the recent acquisition of ZipDoctor, Inc. complement Cosmos Holdings Inc. COSM's existing portfolio and future growth plans in the telehealth space?
In what ways will Cosmos Holdings Inc. COSM leverage its R&D partnerships to enhance its proprietary products while managing investments in digital assets like Ethereum?
**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).
NASDAQ: COSM
COSM Trading
10.1% G/L:
$0.2758 Last:
1,618,807 Volume:
$0.2525 Open:
